Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Optimizing the Care Pathways of Patients Treated for Operable Breast Cancer

NCT02813317 is registered in ClinicalTrials.gov with Institut Curie as lead sponsor.

NCT NCT02813317
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02813317 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Optimizing the Care Pathways of Patients Treated for Operable Breast Cancer
Lead sponsor
Institut Curie
Phase
Observational
Overall status
Completed
Start date
December 31, 2014
Completion date
April 30, 2017
Enrollment
617 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, surgery